Related Experiment Video
Updated: Apr 6, 2026

Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo
Published on: June 2, 2019
Structure, function and toxicity of alpha-synuclein: the Bermuda triangle in synucleinopathies
Anna Villar-Piqué1, Tomás Lopes da Fonseca1,2, Tiago Fleming Outeiro3,4,5
1Department of NeuroDegeneration and Restorative Research, Center for Nanoscale Microscopy and Molecular Physiology of the Brain, University Medical Center Göttingen, Göttingen, Germany.
Parkinson's disease and related synucleinopathies involve alpha-synuclein protein misfolding. Understanding its structure, function, and toxicity is key to developing new therapies for these neurodegenerative disorders.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Synucleinopathies, including Parkinson's disease, are characterized by alpha-synuclein aggregation.
- The exact molecular mechanisms driving synucleinopathy pathogenesis remain unclear.
- Identifying toxic alpha-synuclein forms is crucial for therapeutic development.
Purpose of the Study:
- To review recent findings on alpha-synuclein structure, function, and toxicity.
- To offer new perspectives on persistent paradigms in synucleinopathy research.
- To explore the role of alpha-synuclein in both physiological and pathological conditions.
Main Methods:
- Literature review of recent alpha-synuclein research.
- Analysis of the structure-function-toxicity relationship of alpha-synuclein.
- Discussion of current understanding and future directions in synucleinopathy research.
Main Results:
- Alpha-synuclein aggregation is a central event in synucleinopathies.
- The precise toxic species of alpha-synuclein are not yet definitively identified.
- Research is advancing the understanding of alpha-synuclein's role in disease.
Conclusions:
- Elucidating the structure, function, and toxicity of alpha-synuclein is essential for understanding synucleinopathies.
- Determining alpha-synuclein's causative role is vital for identifying therapeutic targets.
- Further research may lead to novel therapeutic strategies for Parkinson's disease and related disorders.
More Related Videos
09:16Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation
Published on: June 26, 2018
08:40Millisecond Hydrogen/Deuterium-Exchange Mass Spectrometry for the Study of Alpha-Synuclein Structural Dynamics Under Physiological Conditions
Published on: June 23, 2022
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Neural Regulation
Lysosomal Hydrolases
Parkinson's Disease: Overview
ATP Synthase: Mechanism